Sugi Predict

Sugi Predict / Compounds / SCHEMBL173732

SCHEMBL173732

SCHEMBL173732

C=CCc1ccccc1[C]=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.42
▸ GABRB2 P47870 2/20 0.42
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ POLB P06746 1/20 0.33
▸ AKR1B1 P15121 1/20 0.33
▸ ADRA2C P18825 3/20 0.33
▸ ADRA2B P18089 2/20 0.33
▸ HTR1A P08908 2/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ NISCH Q9Y2I1 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ ADRB2 P07550 1/20 0.32
▸ ADRB1 P08588 1/20 0.32
▸ ADRB3 P13945 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ BDKRB2 P30411 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ HTR2B P41595 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4952691 0.84 GABRA1 (0.44) GABRA1GABRB2KDM4EALDH1A1POLB
SCHEMBL10693703 0.83 GABRA1 (0.45) GABRA1GABRB2KDM4EALDH1A1AKR1B1
SCHEMBL14765210 0.82 GABRA1 (0.43) GABRA1GABRB2KDM4EALDH1A1POLB
SCHEMBL4415273 0.81 GABRA1 (0.42) GABRA1GABRB2KDM4EALDH1A1POLB
SCHEMBL28883079 0.80 GABRA1 (0.47) GABRA1GABRB2KDM4EALDH1A1POLB
SCHEMBL3063776 0.79 GABRA1 (0.42) GABRA1GABRB2KDM4EALDH1A1AKR1B1
SCHEMBL7394198 0.79 GABRA1 (0.42) GABRA1GABRB2KDM4EALDH1A1AKR1B1
SCHEMBL2162474 0.79 GABRA1 (0.42) GABRA1GABRB2KDM4EALDH1A1SLC6A2
SCHEMBL10561343 0.79 GABRA1 (0.42) GABRA1GABRB2KDM4EALDH1A1AKR1B1
SCHEMBL3987139 0.78 GABRA1 (0.41) GABRA1GABRB2KDM4EALDH1A1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022048684-A1 JNK INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 武汉朗来科技发展有限公司 2022-03-10 — — WO claimed
CN-114105860-A Catalytic asymmetric synthesis method and application of chiral oxindole spiro-analogue 重庆大学 2022-03-01 — — CN claimed
CN-113735929-A Anti-coronavirus compound and preparation method and application thereof 海化生命(厦门)科技有限公司 2021-12-03 — — CN claimed
US-20210227822-A1 COMPOUNDS FOR PROTECTION OF CELLS SULFATEQ B.V. (NL) 2021-07-29 — — US claimed
US-20190098890-A1 COMPOUNDS FOR PROTECTION OF CELLS SULFATEQ B.V. (NL) 2019-04-04 — — US claimed
EP-3388426-A2 COMPOUNDS FOR PROTECTION OF CELLS Sulfateq B.V. (NL) 2018-10-17 — — EP claimed
US-20160244409-A1 UV Absorbing Compounds, Compositions Comprising Same and Uses Thereof CORAL SUNSCREEN PTY LTD (AU) 2016-08-25 — — US claimed
CN-105793239-A UV ABSORBING COMPOUNDS, COMPOSITIONS COMPRISING SAME AND USES THEREOF 珊瑚防晒私人有限公司 2016-07-20 — — CN claimed
US-20150342174-A1 COMPOUNDS FOR PROTECTION OF CELLS SULFATEQ B.V. (NL) 2015-12-03 — — US claimed
EP-2935232-A1 COMPOUNDS FOR PROTECTION OF CELLS Sulfateq B.V. (NL) 2015-10-28 — — EP claimed
US-RE30241-E BRONCHODILATION, ADRENERGIC STIMULANTS STERLING DRUG INC. (US) 1980-03-25 — — US claimed
US-4192868-A ANTIINFLAMMATORY, ANALGESIC CIBA-GEIGY CORPORATION (US) 1980-03-11 — — US claimed
US-4140683-A DISPERSE DYES FOR POLYESTERS EASTMAN KODAK COMPANY (US) 1979-02-20 — — US claimed
US-4138581-A BRONCHODILATOR AGENTS, ADRENERGIC STIMULANTS STERLING DRUGS INC. (US) 1979-02-06 — — US claimed
US-3998803-A TEXTILES FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) 1976-12-21 — — US claimed
US-3962214-A Process for preparing amino substituted β-lactam antibiotics ELI LILLY AND COMPANY (US) 1976-06-08 — — US claimed
US-3954731-A Process for preparing 6-alkoxypenicillanic and 7-alkoxycephalosporin acids ELI LILLY AND COMPANY (US) 1976-05-04 — — US claimed
US-3941779-A Method for producing 2-(substituted thio)-3-cephem derivatives E. R. SQUIBB & SONS, INC. (US) 1976-03-02 — — US claimed
US-3932393-A 3-Methylenecephalosporins and process for production thereof ELI LILLY AND COMPANY (US) 1976-01-13 — — US claimed
US-3930793-A CONTINUOUS, DISAZO DYES HOECHST AKTIENGESELLSCHAFT (DT) 1976-01-06 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190098890-A1 COMPOUNDS FOR PROTECTION OF CELLS CASP10, BAX, CASP9 GABRA1 3381/4885GABRB2 2589/4885KDM4E 2473/4885
US-20210227822-A1 COMPOUNDS FOR PROTECTION OF CELLS CASP10, BAX, CASP9 GABRA1 3381/4885GABRB2 2589/4885KDM4E 2473/4885
US-20160244409-A1 UV Absorbing Compounds, Compositions Comprising Same and Uses Thereof ERCC4, ERCC1, ERCC5 GABRA1 3798/4885GABRB2 3824/4885KDM4E 1403/4885
US-20150342174-A1 COMPOUNDS FOR PROTECTION OF CELLS CASP10, BAX, CASP9 GABRA1 3381/4885GABRB2 2589/4885KDM4E 2473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.